Segman, Y., Ribakovsky, E., Avigdor, A., Goldhecht, Y., Vainstein, V., Goldschmidt, N., Harlev, S., Horwitz, N., Gutwein, O., Gurion, R., Itchaki, G., Abadi, U., Nemets, A., Sofer, O., Zektser, M., Tadmor, T., Dally, N., Filanovsky, K., Leiba, M., Sarid, N., Benyamini, N., Herishanu, Y., Ram, R., Perry, C., & Avivi, I. (2021). outcome of relapsed/refractory diffuse large B-cell lymphoma patients treated with polatuzumab vedotin-based therapy: real-life experience. Leukemia & lymphoma, 62(1), 118–124. http://access.bl.uk/ark:/81055/vdc_100118922929.0x000034